HQL
Tekla Life Sciences Investors
17.60$
+0.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -357.1% | -468.8% | -1,214.3% | -107.3% | -276.6% | -393.4% | -1,000.0% | -359.6% | -91.3% | -128.5% | 706.6% | 2,826.1% | 104.4% | 20,754.4% | 984.1% | 1.8% | -6.0% | – | – | – | – | – | – | 0.0% | – | – | – | -2.7% | |
| – | – | – | – | – | – | – | – | -31.1% | -64.1% | -19.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 874.2% | -1,317.1% | 1,891.3% | – | – | – | – | – | -16,168.9% | – | – | – | – | – | – | – | – | – | – | – | |
| -357.1% | -468.8% | -1,214.3% | -107.3% | -276.6% | -393.4% | -1,000.0% | -359.6% | -91.3% | -128.5% | 706.6% | 2,826.1% | 104.4% | 20,754.4% | -1.2% | 0.2% | 0.0% | – | – | – | – | – | – | – | – | – | – | -0.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.0% | |
| 119.0% | 2,437.5% | 1,428.6% | 576.3% | 1,021.3% | 1,524.6% | 2,656.3% | 1,101.1% | -2,530.4% | 496.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 29.2% | |
| – | 1,968.8% | 1,142.9% | 457.6% | 766.0% | 967.2% | 1,781.3% | 820.2% | 482.6% | 368.1% | 706.6% | 1,652.2% | 197.8% | 1,964.9% | 476.9% | 1.8% | 1.6% | – | – | – | – | – | – | – | – | – | – | 36.6% | |
| – | – | – | – | – | – | – | – | 3,104.3% | – | – | – | -208.8% | -18,789.5% | -507.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,968.8% | -1,142.9% | -457.6% | -766.0% | -967.2% | -1,781.3% | -820.2% | 2,621.7% | -368.1% | -706.6% | -1,652.2% | -401.1% | -20,754.4% | -984.1% | -1.8% | 6.0% | – | – | – | – | – | – | – | – | – | – | -36.6% | |
| -238.1% | -31.3% | -928.6% | 16.9% | -21.3% | 163.9% | -125.0% | -78.7% | -0.9% | 0.0% | 0.0% | 1,173.9% | -296.7% | – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | 0.0% | – | 0.0% | – | 0.1% | |
| -357.1% | -468.8% | -1,214.3% | -107.3% | -276.6% | -393.4% | -1,000.0% | -359.6% | -91.3% | -128.5% | 706.6% | 2,826.1% | 104.4% | 20,754.4% | 984.1% | 1.8% | -6.0% | – | – | – | – | – | – | 0.0% | – | – | – | -2.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.